Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
002275 Guilin Sanjin Pharmaceutical
- 15.09
- +0.33+2.24%
Market Closed Dec 20 15:00 CST
8.87BMarket Cap21.71P/E (TTM)
15.09High14.64Low34.23KlotVolume14.75Open14.76Pre Close51.24MTurnover0.61%Turnover Ratio21.05P/E (Static)587.57MShares16.7452wk High3.09P/B8.44BFloat Cap10.7352wk Low16.24Limit Up559.04MShs Float32.69Historical High13.28Limit Down3.05%Amplitude4.46Historical Low0.55Dividend TTM14.97Avg Price12.75KlotAsk3.64%Div YieldTTM100Lot Size20.08KlotBid
Guilin Sanjin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -3.49%1.57B | -10.53%1.07B | -32.59%482.59M | 10.81%2.17B | 13.40%1.63B | 19.96%1.19B | 38.51%715.93M | 12.55%1.96B | 14.60%1.44B | 13.13%995.47M |
| Operating revenue | -3.49%1.57B | -10.53%1.07B | -32.59%482.59M | 10.81%2.17B | 13.40%1.63B | 19.96%1.19B | 38.51%715.93M | 12.55%1.96B | 14.60%1.44B | 13.13%995.47M |
| Other operating revenue | ---- | -63.85%2.44M | ---- | -30.63%3.66M | ---- | 107.05%6.75M | ---- | 94.55%5.27M | ---- | 68.30%3.26M |
| Total operating cost | -2.05%1.14B | -4.48%733.37M | -29.15%354.63M | 4.21%1.69B | 9.56%1.16B | 19.27%767.8M | 36.02%500.56M | 17.14%1.62B | 10.61%1.06B | 6.30%643.74M |
| Operating cost | -8.12%396.2M | -15.42%269.99M | -30.92%124.31M | 3.10%586.4M | 8.62%431.23M | 15.09%319.24M | 39.30%179.95M | 27.22%568.78M | 8.17%397M | 2.83%277.39M |
| Operating tax surcharges | -0.59%23.66M | -5.12%17.62M | -43.48%4.9M | 3.46%37.33M | -0.73%23.8M | 2.64%18.57M | 39.27%8.67M | 10.00%36.09M | 12.29%23.97M | 11.51%18.1M |
| Operating expense | 9.53%501.43M | 6.46%291.44M | -14.75%155.07M | 33.35%717.86M | 30.62%457.81M | 59.87%273.74M | 58.89%181.9M | -4.71%538.34M | 13.14%350.49M | 8.34%171.23M |
| Administration expense | -28.25%109.37M | -17.88%76.55M | -24.91%38.77M | -26.07%202.81M | -10.30%152.44M | -14.00%93.22M | 19.82%51.63M | 75.49%274.33M | 55.64%169.95M | 50.78%108.4M |
| Financial expense | 21.20%-4.69M | -30.46%-1.27M | -128.52%-1.5M | 2.27%-14.41M | -2.91%-5.95M | 89.65%-971.89K | 5.18%5.24M | 29.31%-14.74M | 63.89%-5.78M | 36.56%-9.39M |
| -Interest expense (Financial expense) | -69.43%8.2M | -5.66%5.4M | -71.99%3.05M | -19.17%16.36M | 97.00%26.81M | -76.48%5.72M | 194.69%10.9M | 11.12%20.24M | -5.84%13.61M | --24.32M |
| -Interest Income (Financial expense) | 80.45%-6.74M | -13.83%-8.9M | -4.19%-5.49M | 19.86%-31.18M | -39.05%-34.48M | 77.34%-7.82M | -125.51%-5.26M | 0.91%-38.91M | 19.69%-24.8M | ---34.51M |
| Research and development | 9.04%114.85M | 23.49%79.03M | -54.78%33.09M | -27.17%158.06M | -17.31%105.33M | -17.96%64M | 4.43%73.16M | 7.20%217.04M | -24.94%127.38M | -25.33%78.01M |
| Credit Impairment Loss | 4.69%-5.17M | -78.06%-10.04M | -85.52%-13.52M | 99.77%-9.05K | -6,343.84%-5.42M | 23.50%-5.64M | -203.50%-7.29M | -206.15%-3.91M | 102.87%86.86K | -155.92%-7.37M |
| Asset Impairment Loss | 40.63%-3.07M | ---- | ---- | -189.21%-16.17M | -439.92%-5.17M | -96.37%55.19K | -94.82%78.75K | 68.85%-5.59M | --1.52M | --1.52M |
| Other net revenue | 186.90%31.02M | 169.65%20.21M | -3.01%-724.97K | -67.52%34.71M | -53.36%10.81M | 8.21%7.49M | -116.60%-703.8K | 51.43%106.89M | -65.20%23.19M | -63.61%6.93M |
| Fair value change income | 289.40%1.58M | 186.69%753.54K | ---- | 631.94%1.19M | 8.58%-836.6K | 5.01%-869.26K | ---- | -90.79%162.92K | 31.65%-915.14K | 31.65%-915.14K |
| Invest income | 147.18%862.81K | 167.50%351.93K | -565.53%-387.46K | 15.04%1.99M | 4.52%-1.83M | 64.01%-521.4K | 109.84%83.23K | 225.28%1.73M | 2.42%-1.92M | 69.67%-1.45M |
| -Including: Investment income associates | ---- | ---- | ---- | -37,211.81%-1.14M | ---- | ---- | ---- | -28.04%3.07K | ---- | ---- |
| Asset deal income | 275.82%4.14M | 267.96%4.31M | 405.58%4.55M | -94.67%1.67M | -2,325.76%-2.35M | -333,029.09%-2.56M | ---1.49M | 106.58%31.24M | -99.32%105.7K | -100.00%-769.7 |
| Other revenue | 23.68%32.68M | 45.82%24.84M | 9.05%8.63M | -44.70%46.04M | 8.71%26.42M | 12.49%17.03M | 14.97%7.91M | 15.01%83.25M | -57.67%24.3M | 26.26%15.14M |
| Operating profit | -2.71%464.99M | -18.12%355.25M | -40.73%127.23M | 16.00%518.26M | 19.74%477.92M | 20.97%433.86M | 40.20%214.66M | 4.14%446.78M | 10.49%399.14M | 22.27%358.66M |
| Add:Non operating Income | -23.91%466.51K | -43.23%237.29K | -83.78%39.96K | -25.89%561.46K | -36.68%613.12K | -33.01%417.99K | -58.03%246.39K | -14.84%757.61K | 47.78%968.22K | -26.20%624K |
| Less:Non operating expense | -51.19%465.55K | 12.86%360.84K | -35.41%74.95K | -60.22%540.68K | -76.92%953.75K | 49.10%319.71K | -3.18%116.03K | 56.74%1.36M | 873.46%4.13M | 74.74%214.43K |
| Total profit | -2.64%464.99M | -18.16%355.13M | -40.78%127.19M | 16.16%518.28M | 20.61%477.58M | 20.85%433.96M | 39.86%214.79M | 3.99%446.18M | 9.55%395.98M | 22.11%359.07M |
| Less:Income tax cost | 0.53%81.11M | -0.48%54.16M | -40.36%27.18M | -16.86%96.99M | 12.70%80.68M | -3.10%54.42M | 35.91%45.57M | 36.69%116.65M | 4.41%71.59M | 19.82%56.16M |
| Net profit | -3.28%383.88M | -20.70%300.97M | -40.90%100.02M | 27.85%421.3M | 22.35%396.89M | 25.30%379.54M | 40.96%169.23M | -4.13%329.53M | 10.75%324.38M | 22.54%302.92M |
| Net profit from continuing operation | -3.28%383.88M | -20.70%300.97M | -40.90%100.02M | 27.85%421.3M | 22.35%396.89M | 25.30%379.54M | 40.96%169.23M | -4.13%329.53M | 10.75%324.38M | 22.54%302.92M |
| Net profit of parent company owners | -3.28%383.88M | -20.70%300.97M | -40.90%100.02M | 27.85%421.3M | 22.35%396.89M | 25.30%379.54M | 40.96%169.23M | -4.13%329.53M | 10.75%324.38M | 22.54%302.92M |
| Earning per share | ||||||||||
| Basic earning per share | -4.41%0.65 | -21.54%0.51 | -41.38%0.17 | 28.57%0.72 | 23.64%0.68 | 22.64%0.65 | 38.10%0.29 | -6.67%0.56 | 8.03%0.55 | 23.26%0.53 |
| Diluted earning per share | -4.41%0.65 | -21.54%0.51 | -41.38%0.17 | 28.57%0.72 | 23.64%0.68 | 22.64%0.65 | 38.10%0.29 | -6.67%0.56 | 8.03%0.55 | 23.26%0.53 |
| Other composite income | 47.40%-13.33M | -27.42%-11.84M | -377.78%-9.27M | -260.78%-36.85M | -294.63%-25.34M | -253.84%-9.3M | -292.03%-1.94M | 953.45%22.92M | 802.28%13.02M | 618.03%6.04M |
| Other composite income of parent company owners | 47.40%-13.33M | -27.42%-11.84M | -377.78%-9.27M | -260.78%-36.85M | -294.63%-25.34M | -253.84%-9.3M | -292.03%-1.94M | 953.45%22.92M | 802.28%13.02M | 618.03%6.04M |
| Total composite income | -0.27%370.55M | -21.91%289.13M | -45.75%90.75M | 9.08%384.45M | 10.12%371.55M | 19.84%370.25M | 39.92%167.28M | 3.35%352.45M | 15.93%337.4M | 25.58%308.96M |
| Total composite income of parent company owners | -0.27%370.55M | -21.91%289.13M | -45.75%90.75M | 9.08%384.45M | 10.12%371.55M | 19.84%370.25M | 39.92%167.28M | 3.35%352.45M | 15.93%337.4M | 25.58%308.96M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
